The ROE as of December 2024 (TTM) for Cognition Therapeutics, Inc. (CGTX) is -150.93%

According to Cognition Therapeutics, Inc.’s latest financial reports and current stock price. The company's current ROE is -150.93%. This represents a change of 267.69% compared to the average of -41.05% of the last 4 quarters.

Cognition Therapeutics, Inc. (CGTX) Historical ROE (quarterly & annually)

How has CGTX ROE performed in the past?

The mean historical ROE of Cognition Therapeutics, Inc. over the last ten years is -19.37%. The current -150.93% ROE has changed 678.99% with respect to the historical average. Over the past ten years (40 quarters), CGTX's ROE was at its highest in in the March 2020 quarter at 45.61%. The ROE was at its lowest in in the September 2024 quarter at -68.62%.

Cognition Therapeutics, Inc. (CGTX) ROE by Quarter and Year

Discovering the peaks and valleys of Cognition Therapeutics, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Cognition Therapeutics, Inc. (CGTX) Average ROE

How has CGTX ROE performed in the past?

The current ROE of Cognition Therapeutics, Inc. (CGTX) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Cognition Therapeutics, Inc. (CGTX) ROE vs. Peers

How is CGTX’s ROE compared to its peers?

Cognition Therapeutics, Inc.’s ROE is less than Reviva Pharmaceuticals Holdings, Inc. (1.15%), greater than Eyenovia, Inc. (-1243.79%), greater than TransCode Therapeutics, Inc. (-649.01%), greater than Kodiak Sciences Inc. (-84.52%), greater than TFF Pharmaceuticals, Inc. (-310.17%), greater than TScan Therapeutics, Inc. (-58.72%), greater than Cue Biopharma, Inc. (-156.38%), greater than Dermata Therapeutics, Inc. (-247.40%), greater than Gain Therapeutics, Inc. (-203.91%), greater than aTyr Pharma, Inc. (-56.83%), greater than IN8bio, Inc. (-197.15%), greater than Lantern Pharma Inc. (-56.90%), less than Cullinan Oncology, Inc. (0%), greater than Bolt Biotherapeutics, Inc. (-26.54%), greater than Day One Biopharmaceuticals, Inc. (-69.46%), greater than Lyra Therapeutics, Inc. (-22.40%), greater than Autolus Therapeutics plc (-178.68%), greater than null (-63.65%),

Build a custom stock screener for Cognition Therapeutics, Inc. (CGTX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Cognition Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Cognition Therapeutics, Inc. (CGTX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Cognition Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.